# BMED holdings and overlap

iShares Health Innovation Active ETF, Health Care, iShares.

Canonical page: https://tickerinside.com/etf/bmed/
Holdings from the issuer file published 2026-09-03. Prices through 2026-09-04.
Licence: CC BY 4.0, attribution to TickerInside. Measurements, not investment advice.

## Largest positions, issuer file of 2026-09-03

| Rank | Ticker | Company | Weight |
| --- | --- | --- | --- |
| 1 | GILD | Gilead Sciences | 5.08% |
| 2 | [MRK](https://tickerinside.com/stock/mrk/) | Merck & Co Inc | 5.05% |
| 3 | [ABBV](https://tickerinside.com/stock/abbv/) | Abbvie | 4.59% |
| 4 | [JNJ](https://tickerinside.com/stock/jnj/) | Johnson & Johnson | 4.39% |
| 5 | CRL | Charles River Laboratories Interna | 4.22% |
| 6 | TMO | Thermo Fisher Scientific Inc | 4.05% |
| 7 | MRNA | Moderna | 4.02% |
| 8 | EW | Edwards Lifesciences | 3.83% |
| 9 | IQV | Iqvia Holdings | 3.79% |
| 10 | VRTX | Vertex Pharmaceuticals | 3.58% |
| 11 | DHR | Danaher | 3.53% |
| 12 | BIIB | Biogen | 3.5% |
| 13 | WAT | Waters Corp | 3.45% |
| 14 | MTD | Mettler Toledo | 2.99% |
| 15 | AMGN | Amgen Inc | 2.59% |
| 16 | ROP | Roche PS Par AG | 2.58% |
| 17 | DXCM | Dexcom Inc | 2.53% |
| 18 | INCY | Incyte Corp | 2.44% |
| 19 | ILMN | Illumina Inc | 2.19% |
| 20 | ARGX | Argenx SE ADR | 2.12% |
| 21 | NOVN | Novartis AG | 2.07% |
| 22 | HALO | Halozyme Therapeutics | 2.04% |
| 23 | CYTK | Cytokinetics | 1.55% |
| 24 | PFE | Pfizer | 1.54% |
| 25 | BMY | Bristol Myers Squibb | 1.51% |

All 51 positions with weights: https://tickerinside.com/api/v1/fund/bmed.json

## Key figures

| Measure | Value |
| --- | --- |
| Last close, 2026-09-04 | 34.03 USD (-1.13% on the day) |
| Expense ratio | 0.55% |
| Positions | 51 |
| Weight in the ten largest | 42.6% |
| Total return, 1 year | 27.5% |
| Total return, 3 years | 45.1% |
| Volatility, annualised | 17.3% |
| Worst fall, 3 years | -16.2% |
| Beta against SPY | 0.68 |

## What does BMED share with other funds?

| Fund | Overlap by weight | Of BMED held there | Of that fund in BMED | Companies in both |
| --- | --- | --- | --- | --- |
| IXJ | 39.3% | 78.2% | 47.1% | 25 |
| IYH | 39.0% | 80.6% | 52.5% | 30 |
| XLV | 37.3% | 69.3% | 52.1% | 20 |
| RSPH | 36.7% | 69.3% | 37.9% | 20 |
| VHT | 36.4% | 89.3% | 45.4% | 39 |
| IBB | 34.2% | 46.3% | 50.8% | 26 |
| IBBQ | 33.4% | 41.8% | 49.7% | 24 |
| PJP | 29.2% | 30.2% | 43.0% | 9 |
| PBE | 27.6% | 29.6% | 41.3% | 11 |
| XBI | 20.4% | 39.2% | 24.8% | 22 |
| IDNA | 18.1% | 19.9% | 29.8% | 7 |
| XT | 18.0% | 51.9% | 18.1% | 16 |


Method: https://tickerinside.com/how-the-numbers-are-produced/